Nectin Therapeutics recently secured a significant $10.00M in a Venture Round investment on 06 May 2024 from GIBF Fund. The company's vision and innovative approach in the biotechnology industry make it a promising investment opportunity in the field of immunotherapy and cancer treatment.
Nectin Therapeutics
Unlocking the power of the immune system - next-generation immunotherapy
Founded 2017
Israel
12 employees
Venture round
Total: $46.40M
Biotechnology, Life Sciences
Israel
12 employees
Venture round
Total: $46.40M
Biotechnology, Life Sciences
General Information
Company Name
Nectin Therapeutics
Founded Year
2017
Location
Israel
Israel
Employees
12
Industries
Biotechnology, Life Sciences
Funding Stage
Venture round
Social
BounceWatch is an independent company data service, not affiliated with Nectin Therapeutics. To contact Nectin Therapeutics, visit nectintx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Nectin Therapeutics compare?
A PDF of Nectin Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Nectin Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Nectin Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Israel Market
Biotechnology
About Nectin Therapeutics
Business keywords: biotech, immunotherapy, cancer therapy, immune system, therapeutic agents, antibodies, resistance mechanisms, CAR-T, CAR-NK, targeted therapy, oncology, novel agents, immune cell, tumor targeting, drug development
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $10.00M | 1 |
GIBF Fund
|
06 May 2024 |
| Grant | Undisclosed | 1 |
EIC Accelerator
|
28 Feb 2024 |
| Series A | $25.00M | 3 |
|
30 Nov 2022 |
| Series A | $5.40M | 1 |
|
07 Mar 2022 |
| Venture Round | $6.00M | 1 |
|
14 Jul 2020 |
| Seed Round | Undisclosed | 1 |
|
01 Jan 2017 |
Nectin Therapeutics Alternatives & Competitors
View All Alternatives
Nectin Therapeutics vs
Taiga Biotechnologies
United States
Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the power of t...
Seed
1 employees
Biotechnology, Health and Wellness
Nectin Therapeutics vs
ImmunoGenesis, Inc.
United States
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of...
Venture round
14 employees
Biotechnology, Health Care
Nectin Therapeutics vs
IOME BIO
France
Harnessing unique, proprietary microbiome insights to unlock the efficacy of immuno-oncology
4 employees
Biotechnology, Health Care
FAQ About Nectin Therapeutics
Unlocking the power of the immune system - next-generation immunotherapy
Nectin Therapeutics was founded in 2017.
Nectin Therapeutics is headquartered in Israel.
Nectin Therapeutics operates in Biotechnology and Life Sciences. Its work centres on biotech, immunotherapy, cancer therapy and immune system.
Nectin Therapeutics has approximately 12 employees.
Nectin Therapeutics has completed 6 funding rounds, raising a total of $46.40M. The latest funding stage is Venture round.
Top alternatives and competitors to Nectin Therapeutics include Taiga Biotechnologies, ImmunoGenesis, Inc., IOME BIO, Enterome, Bicara Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nectin Therapeutics and Taiga Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Nectin Therapeutics, https://bouncewatch.com/company/nectin-therapeutics, updated 25 November 2024. When citing, please name BounceWatch and link this page.
